Xue Ling-Wei, Fu Xu, Zhao Gan-Qing, Li Qing-Bin
Acta Chim Slov. 2021 Mar;68(1):17-24.
Three new zinc(II) complexes, [Zn2I2(L1)2] (1), [Zn(HL2)2(NCS)2] (2), and [ZnIL3] (3), where L1 is the anionic form of 2-[(6-methylpyridin-2-ylimino)methyl]phenol (HL1), HL2 is the zwitterionic form of 2-(cyclopropyliminomethyl)-5-fluorophenol (HL2), and L3 is the anionic form of 5-bromo-2-[(3-morpholin-4-ylpropylimino)methyl]phenol (HL3), have been prepared and characterized by elemental analyses, IR, UV and NMR spectra, and single crystal X-ray crystallographic determination. Complex 1 is a dinuclear zinc complex, and complexes 2 and 3 are mononuclear zinc complexes. The Zn atoms in the complexes are in tetrahedral coordination. The effect of the complexes on the antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans were evaluated.
制备了三种新型锌(II)配合物,即[Zn2I2(L1)2](1)、[Zn(HL2)2(NCS)2](2)和[ZnIL3](3),其中L1是2-[(6-甲基吡啶-2-基亚氨基)甲基]苯酚(HL1)的阴离子形式,HL2是2-(环丙基亚氨基甲基)-5-氟苯酚(HL2)的两性离子形式,L3是5-溴-2-[(3-吗啉-4-基丙基亚氨基)甲基]苯酚(HL3)的阴离子形式,并通过元素分析、红外光谱、紫外光谱和核磁共振光谱以及单晶X射线晶体学测定对其进行了表征。配合物1是双核锌配合物,配合物2和3是单核锌配合物。配合物中的锌原子呈四面体配位。评估了这些配合物对金黄色葡萄球菌、大肠杆菌和白色念珠菌的抗菌活性。